海思科：环泊酚注射液获拓展儿童人群批准

Core Viewpoint - The company has received approval from the National Medical Products Administration for its product, which is now authorized for use in pediatric and adolescent anesthesia induction and maintenance [1] Group 1: Company Announcement - Subsidiary Shenyang Haishi Pharmaceutical Co., Ltd. has been granted a Supplementary Application Approval Notice for the drug, Ropivacaine Injection (Sishuning) [1] - The approval aligns with the drug registration requirements and includes revisions to the safety information in the product's instructions [1]